Quantcast

Latest Aromatase inhibitor Stories

2014-09-15 16:28:40

Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept. 15, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB) today announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD). Romosozumab is an investigational bone-forming agent that is designed to work by inhibiting the protein sclerostin, thereby...

2014-09-10 08:32:41

Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will present data from multiple Prolia(®) (denosumab) and romosozumab study analyses at the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting being held in Houston, Sept. 12-15, 2014. The data that will be...

Real And Sham Acupuncture Effective Chemo Side Effects
2013-12-23 10:08:16

Brett Smith for redOrbit.com - Your Universe Online Is acupuncture a legitimate medical treatment? Or is it a centuries-old scam? Maybe the question should really be: Does it matter? According to a new study published on Monday in the journal Cancer, a team of American researchers has found that both real and “sham” acupuncture were able to reduce hot flashes that were a side effect of anticancer drugs called aromatase inhibitors (AI). The drugs block estrogen production in...

2013-12-03 11:13:26

Researchers from the University of Alberta and Alberta Health Services have created a computer algorithm that successfully predicts whether estrogen is sending signals to cancer cells to grow into tumors in the breast. By finding this hormone receptor, known as estrogen receptor positive, physicians can prescribe anti-estrogen drug therapies, improving patient outcomes. Since each cell in the body contains 23,000 genes, identifying the specific genes involved in cancer growth is an...

2012-10-01 16:32:24

Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in BioMed Central's open access journal Breast Cancer Research shows that women whose HER2 positive cancer was also hormone (estrogen and progesterone) receptor (HR) negative had an increased risk of early death, and that their cancer was less likely to recur in bone than those whose cancer retained hormone sensitivity. Breast...

2012-05-18 11:39:57

Researchers from Baylor College of Medicine have been awarded more than $5 million from Susan G. Komen for the Cure for three new breast cancer research grants, including a prestigious Komen Promise Grant. Komen Promise Grant The Komen Promise Grant is a three-year award for a total of $4,066, 940 to study restoration of endocrine therapy sensitivity in recurrent breast cancers. The grant was awarded to principal investigator Dr. Bert O'Malley, chair of molecular and cellular biology at...

2012-04-04 10:08:00

The findings suggest that new therapies targeting estrogen's metabolism may help prevent or treat lung cancer The hormone estrogen may help promote lung cancer– including compounding the effects of tobacco smoke on the disease–pointing towards potential new therapies that target the hormone metabolism, according to new research presented at the AACR Annual Meeting 2012 on Tuesday, April 3 by scientists at Fox Chase Cancer Center in Philadelphia. "This research provides the...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related